Further,
for the in-depth analysis, the report encompasses the industry growth
indicators, restraints, supply and demand risk, along with detailed discussion
on current and future market trends that are associated with the growth of the
market.
Download Sample of This Strategic Report@ https://www.researchnester.com/sample-request-3605
The global
digital therapeutic market is
anticipated to attain a CAGR of ~25% over the forecast period, i.e., 2022 –
2030. The market is segmented on the basis of application into nutrition care, diabetes, cardiovascular diseases,
chronic respiratory diseases, musculoskeletal disorder, gastrointestinal, substance abuse, rehabilitation, and
others out of which, the diabetes segment is foreseen to attain a
noteworthy share over the forecast period, owing to the rising cases of
diabetes across the world, backed by unhealthy diet, lack of exercise, and
stressful lifestyle of the people. According to the data by the World Health Organization (WHO), an
estimated 422 million people suffer from diabetes mellitus worldwide, as of
2020.
The global
digital therapeutic market is
estimated to experience growth on the back of Increasing health awareness
amongst the people globally, along with the rising penetration of preventive
care practices to avoid or control the diseases. Moreover, the increasing
adoption of technology, and rapid acceptance of digital health tracking
devices, are expected to boost the market growth over the forecast period. Rising
cases of lifestyle diseases and growing mortality rate due to these diseases,
also promote the adoption of preventive healthcare. Such factors are estimated
to boost the market growth.
On the basis of geographical analysis, the
global digital therapeutic market is segmented into five major regions including North America,
Europe, Asia Pacific, Latin America and Middle East & Africa region. The
market in the North America region is projected to gain the largest market
share throughout the forecast period owing to the rising incidences of
lifestyle diseases in the region. According to the data by the U.S. Center for
Disease Control and Prevention (CDC), heart diseases were responsible for over 659,041
deaths in the U.S. Moreover, rising health awareness in the region is estimated
to boost the market growth.
The research is
global in nature and covers detailed analysis on the market in North America
(U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium,
Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark],
Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico,
Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South
Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of
Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain,
Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and
Africa). In addition, analysis comprising market size, Y-O-Y growth &
opportunity analysis, market players’ competitive study, investment
opportunities, demand for future outlook etc. has also been covered and
displayed in the research report.
More
Information@ https://www.researchnester.com/reports/digital-therapeutic-market/3605
Increasing
Adoption of Preventive Healthcare to Boost the Market Growth
The
increasing prevalence of lifestyle diseases, such as, diabetes, cardiovascular
diseases, hypertension, and others, have resulted in raised awareness amongst
individuals for the adoption of preventive measures. The combination of
preventive care practices with technology, is estimated to boost the market
growth. Moreover, availability of trackers, mobile applications, and software
to govern the health and fitness, is estimated to boost the market growth.
However, lack of healthcare infrastructure
is expected to operate as key restraint to the growth of the global digital therapeutic market over the
forecast period.
This
report also provides the existing competitive scenario of some of the key
players of the global digital
therapeutic market which includes company profiling of Akili Interactive
Labs, Inc., Omada Health, Inc., Koninklijke Philips N.V., WellDoc, Inc., Noom,
Inc., Pear Therapeutics, Inc., Teladoc Health, Inc., Click Therapeutics, Inc.,
and Ayogo Health Inc. The profiling enfolds key information of the
companies which encompasses business overview, products and services, key
financials and recent news and developments. On the whole, the report depicts
detailed overview of the global digital
therapeutic market that will help industry consultants, equipment
manufacturers, existing players searching for expansion opportunities, new
players searching possibilities and other stakeholders to align their market
centric strategies according to the ongoing and expected trends in the
future.
Request
Report Sample@ https://www.researchnester.com/sample-request-3605
Research Nester is a leading service provider for
strategic market research and consulting. We aim to provide unbiased,
unparalleled market insights and industry analysis to help industries,
conglomerates and executives to take wise decisions for their future marketing
strategy, expansion and investment etc. We believe every business can expand to
its new horizon, provided a right guidance at a right time is available through
strategic minds. Our out of box thinking helps our clients to take wise
decision in order to avoid future uncertainties.
Contact for more
Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
%20Security%20Market.jpg)
No comments:
Post a Comment